M&A Deal Summary |
|
|---|---|
| Date | 2014-07-01 |
| Target | Viracor-IBT Laboratories |
| Sector | Life Science |
| Buyer(s) | Eurofins Scientific |
| Sellers(s) | Ampersand Capital Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 255M USD |
| Advisor(s) | Lazard Middle Market (Financial) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1987 |
| Sector | Life Science |
| Employees | 62,000 |
| Revenue | 6.5B EUR (2023) |
Eurofins Scientific is an international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments. Eurofins Scientific was incorporated in 1987 and is based in Luxembourg City.
| DEAL STATS | # |
|---|---|
| Overall | 26 of 98 |
| Sector (Life Science) | 24 of 74 |
| Type (Add-on Acquisition) | 11 of 73 |
| State (Missouri) | 1 of 1 |
| Country (United States) | 8 of 31 |
| Year (2014) | 9 of 10 |
| Size (of disclosed) | 3 of 11 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-05-06 |
Calscience Environmental Laboratories
Garden Grove, California, United States Calscience Environmental Laboratories is an environmental and marine chemistry laboratory testing field. Company offer a comprehensive portfolio of analytical methods and company analytical expertise encompasses all environmental matrices including, air, groundwater, sea water, sediment, soil, solid waste, stormwater, tissue and wastewater. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-07-02 |
Analytical Technology Serviços Analíticos e Ambientais
São Paulo, Brazil Analytical Technology is a company specialized in providing chemical analysis services providing a range of products and solutions developed with differentiated analytical standard. It is also one of the major laboratories for water, air and soil testing, as well as for oil geochemistry analysis. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 21 of 55 |
| Sector (Life Science) | 8 of 25 |
| Type (Add-on Acquisition) | 15 of 38 |
| State (Missouri) | 2 of 3 |
| Country (United States) | 21 of 51 |
| Year (2014) | 1 of 2 |
| Size (of disclosed) | 6 of 13 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-02-18 |
IFP
Faribault, Massachusetts, United States IFP is a provider of innovative powdered solutions and specialty ingredients to the global food and beverage, health and wellness and medical nutrition markets. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-10-29 |
Chantest
Cleveland, Ohio, United States ChanTest, is a provider of specialized laboratory testing services for drug development. ChanTest specializes in measuring interactions between drug candidates and proteins known as ion channels. |
Sell | - |
